American Research & Management Company’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | $28K | Hold |
135
| – | – | 0.01% | 232 |
|
2022
Q2 | $32K | Hold |
135
| – | – | 0.01% | 223 |
|
2022
Q1 | $24K | Hold |
135
| – | – | 0.01% | 256 |
|
2021
Q4 | $29K | Hold |
135
| – | – | 0.01% | 235 |
|
2021
Q3 | $25K | Buy |
135
+35
| +35% | +$6.48K | 0.01% | 244 |
|
2021
Q2 | $18K | Hold |
100
| – | – | ﹤0.01% | 281 |
|
2021
Q1 | $17K | Hold |
100
| – | – | ﹤0.01% | 267 |
|
2020
Q4 | $15K | Hold |
100
| – | – | ﹤0.01% | 276 |
|
2020
Q3 | $10K | Hold |
100
| – | – | ﹤0.01% | 263 |
|
2020
Q2 | $12K | Hold |
100
| – | – | ﹤0.01% | 263 |
|
2020
Q1 | $9K | Hold |
100
| – | – | ﹤0.01% | 266 |
|
2019
Q4 | $9K | Hold |
100
| – | – | ﹤0.01% | 275 |
|
2019
Q3 | $8K | Hold |
100
| – | – | ﹤0.01% | 282 |
|
2019
Q2 | $8K | Hold |
100
| – | – | ﹤0.01% | 289 |
|
2019
Q1 | $12K | Hold |
100
| – | – | ﹤0.01% | 313 |
|
2018
Q4 | $11K | Hold |
100
| – | – | ﹤0.01% | 270 |
|
2018
Q3 | $13K | Hold |
100
| – | – | ﹤0.01% | 280 |
|
2018
Q2 | $11K | Buy |
100
+50
| +100% | +$5.5K | ﹤0.01% | 266 |
|
2018
Q1 | $6K | Hold |
50
| – | – | ﹤0.01% | 322 |
|
2017
Q4 | $7K | Hold |
50
| – | – | ﹤0.01% | 316 |
|
2017
Q3 | $6K | Hold |
50
| – | – | ﹤0.01% | 294 |
|
2017
Q2 | $6K | Hold |
50
| – | – | ﹤0.01% | 290 |
|
2017
Q1 | $7K | Hold |
50
| – | – | ﹤0.01% | 274 |
|
2016
Q4 | $7K | Hold |
50
| – | – | ﹤0.01% | 291 |
|
2016
Q3 | $6K | Hold |
50
| – | – | ﹤0.01% | 306 |
|
2016
Q2 | $5K | Hold |
50
| – | – | ﹤0.01% | 298 |
|
2016
Q1 | $6K | Hold |
50
| – | – | ﹤0.01% | 303 |
|
2015
Q4 | $8K | Hold |
50
| – | – | ﹤0.01% | 283 |
|
2015
Q3 | $7K | Hold |
50
| – | – | ﹤0.01% | 301 |
|
2015
Q2 | $9K | Hold |
50
| – | – | ﹤0.01% | 289 |
|
2015
Q1 | $9K | Hold |
50
| – | – | ﹤0.01% | 289 |
|
2014
Q4 | $6K | Buy |
+50
| New | +$6K | ﹤0.01% | 309 |
|